Earnings Call: Q3 2016

Oct 27, 2016

Good afternoon, ladies and gentlemen, and welcome to the Wacker Chemie AG Conference Call regarding the Third Quarter Results 2016. At this time, all participants have been placed on a listen only mode. The floor will be opened for questions following the presentation. Let me now turn the floor over to your host, Mr. Jorg Hoffmann. Thank you, operator. Welcome to the Wacker Chemie AG Q3 twenty sixteen conference call. My name is Joerg Kochmann, and I'm the Head of Investor Relations at Wacker. With me are Doctor. Ulla Staudigl, our CEO and Doctor. Tobias Ola, our CFO, who will take you through our presentations in a minute. The presentation is available on our webpage under www.barker.com, under the caption Investor Relations. Before they begin, allow me to point you to our safe harbor statement, which you'll find at the beginning of the deck. With this, let me hand you now over to Doctor. Stalligle, CEO. Doctor. Stalligle. Thank you, Jorg. Ladies and gentlemen, also welcome to our Q3 twenty sixteen conference call. Let me walk you through our presentation, starting on Page two with the Q3 highlights. We reported a good quarter in Q3. Our chemicals businesses continued their strong operations, supported by efficiency gains and good volumes. Polysilicon saw a split quarter with two good months in July and August and weak volumes in September. Sales came in at €1,350,000,000 slightly below both last year and last quarter. Supported by volume gains and a good cost performance, EBITDA reached $3.00 €1,000,000 representing a 22.4% margin. Excluding special income, EBITDA was even 22% better than last year. Good volume and efficiency gains continue to drive Chemicals EBITDA. Siltronic saw higher sales in a firmer demand environment. At Polysilicon, we have completed the technical ramp up of our tenancy plant. The plant has demonstrated its capacity and has now started to work on productivity, process optimization and cost reductions. Therefore, we do not see the need to report on ramp costs anymore. There was also no special income in the quarter. The market environment in Polysilicon was volatile in Q3. With July and August rather uneventful, September saw very weak volumes. With the Chinese end market halting at the July, customers had inventory for a much higher run rate of production and reduced orders as a result. Many of our peers went into maintenance mode or chose to add to inventory in this time. Some of you have described this as an air pocket, and I think that is a good description of how it felt. We used this opportunity to optimize our logistics, given the long distance to our main markets from Germany to Asia. Since the mid October, however, the market has rebounded. Orders and volumes have increased substantially. We have concluded our eighth Capital Markets Day earlier this month in Bergkowen. You'll find the Capital Markets Day presentations on our website. In our main Capital Markets Day presentation called Growth and Cash, we presented five targets for the next year. These are shown on Page three of today's slide. First, we intend to extend our leverage phase to 2020 at least. As you know, we have described our investment program over the last decade with development stages. With the tenancy investment now behind us, we have definitely concluded the create phase of this model. Now we are looking to a leverage phase into 2020, during which we expect to benefit from our strong upstream position. We plan to keep CapEx below depreciation and to focus on local investments, debottlenecking and smaller projects that take us closer to the customer and increase value creation. Second, we look to continue to grow faster than global chemical production. Our good product positions and access to markets will enable us to get there. Market transformation, innovation and regional expansion are key drivers for this growth. Thirdly, we continue to focus on sustainability. With our so called Verbund integrated production system, we already have an optimized structure in place that looks at waste streams as valuable inputs for other businesses. Our processing and product strategy supports this. From enabling solar growth to water based paints and leading insulation material, Backe's portfolio has a clear focus on sustainable business development and growth. Fourth, with target EBITDA margins in Chemicals of over 16% and in Polysilicon of more than 30%, we should generate significant free cash flows going forward. Our businesses should be able to sustain attractive margins throughout the economic cycle. Fifth, for the leverage phase, we have now defined a new target level for dividend, looking to pay out around 50% of our net income to shareholders going forward. Our previous target was to pay out a minimum of 25% of net income. This year, we have concluded the largest investment in our history. With the Teneti Plant Nagel operation, our CapEx comes down significantly compared to last year. We expect to spend about €400,000,000 less this year than in 2015, and the reduction has not slowed our growth in Chemicals. Looking into the fourth quarter, we expect the usual seasonal behavior in our Chemicals businesses with high utilization in Siltronic and a livelier Q4 business than in September in polysilicon. Hence, our guidance for the full year remains unchanged. We continue to expect a slight increase in sales and the full year EBITDA, excluding special income, to come in at the upper end of our projected 5% to 10% increase over last year. Let me now hand over to Tobias for more details on our financials. Thank you, Rudy. Let me start with our P and L on Page five. We reported an EBITDA of $3.00 €1,000,000 14% over last year and at the level of Q2. The resulting group level EBITDA margin was 22.4%, While Q3 last year saw some €80,000,000 in special income, we reported none in this quarter. As the Tennessee plant reached technical completion during the quarter and demonstrated its capacity, we essentially had no more ramp costs. You can see these effects in the year over year comparison of the other operating income and expenses. The interest result is lower than last year as we had to capitalize interest during the construction period in 2015. Our nine month tax rate decreased faster than expected to the target rate of close to 30% following special tax effects overseas. We expect a tax rate close to 30% now for the full year and for 2017. Our balance sheet is discussed on Page six. Prepayments at the end of the quarter were down to €322,000,000 in line with guidance. Working capital stood at €1,300,000,000 following a combination of slightly higher inventories and lower payables. Following lower bond rates, the discount factor for pension declined to 1.38% from 1.6% at the end of last quarter, resulting in an increase in pension liabilities from €2,420,000,000 to €2,570,000,000 The pension related deferred tax asset now stands at about €440,000,000 These pension liabilities relate to defined benefit plans that were closed to new entries over twelve years ago. Since then, new employees are on defined contribution schemes. We discussed this at our Capital Markets Day, so you will find slides on this in the presentation. Let's move on to our segments from Page seven. The Chemical businesses also saw some price pressure and solid volumes, while benefiting from high plant loading. Our Chemicals businesses contributed almost two thirds of EBITDA in Q3. Silicones reported sales at the level of prior year and slightly below the last quarter following good volumes, negative currency effects and some price pressure in selected product groups. Good plant loading, a good cost performance and mix effects supported an EBITDA margin of 20% in the quarter. Sales in Polymers were below prior year and last quarter as strong volumes in Dispersions did not fully offset price declines in various product groups. Year over year EBITDA benefited from volumes and high plant loading, leading to a good cost performance. Absolute EBITDA was lower than in Q2 following lower sales and some raw material cost inflation. Looking into the full year, we confirm our guidance for the Chemicals segment at single digit growth with full year EBITDA margins at 17% for Silicones and about 20% for Polymers. At our Capital Market Day, we communicated an over 16% margin target for our Chemicals businesses. We plan to sustain margins over 16% in Chemicals via operational excellence and with an increasing share of specialty applications. As Ruliset, polysilicon saw weak September volumes. As a result, sales in the quarter fell behind last year and Q2. At €82,000,000 EBITDA was only slightly ahead of reported Q2 as ramp costs faded. EBITDA was over 10% better than last year when adjusting for special income. We have seen some market recovery since mid October. We continue to operate at full loading and to focus on cost reduction. Our market growth projections for this year look into twenty sixteen global installations of between sixty seventy gigawatts after about 56 gigawatts in 2015. We believe that the market could come out at the upper end of the range. And for 2017, we now see installations between 65 to 80 gigawatts. Siltronic reported today Q3 sales of €237,000,000 and an EBITDA of €37,000,000 both slightly better than Q2 and EBITDA better than last year following lower FX charges. Operating at full capacity in Q3 in three hundred and two hundred millimeter, Siltronic shipped wafers out of inventory to meet the strong demand. With firm demand for wafers, Siltronic sees tight market conditions in three hundred and two hundred millimeter in the fourth quarter. Our net financial debt decreased to €968,000,000 following a strong cash flow generation in Q3. Net cash flow in Q3 came in at €229,000,000 over 80% better than in Q2 and more than six times better than in Q3 last year. CapEx in the quarter was at €99,000,000 at less than half of the amount spent in Q3 last year and only slightly higher than in Q2. Now let me hand you back to Rudi. Thank you, Xavier. Before we go into Q and A, let's have a quick look at current trading conditions. In the fourth quarter, we expect the usual seasonal effects in Chemicals, resulting in lower sales and EBITDA. Especially in polymers, we expect effects from some raw material appreciation as ethylene costs have gone up. From today's point of view, however, some of the seasonal effects in silicones may be cushioned by silicon metal price decreases. Polysilicon reports increased activity with strong shipments resumed by about mid October. Siltronic reports market tightness in two hundred and three hundred millimeter with operations at very high utilization rates in the industry. We remain confident about our performance for the full year and expect to reach the upper end of the range of our guidance for EBITDA, excluding special income, effectively targeting an EBITDA for the full year of about €1,000,000,000 And as we said last time, if everything goes well, we could slightly exceed it. This concludes the presentation so far, ladies and gentlemen. Thank you for your attention. We will now be happy to answer your questions. Operator? Operator, the first question is from Mr. Andreas Heine from MainFirst. I'd like to ask on polysilicon. If I look on your comments that the volume was sequentially significantly down from Q2 to Q3. And looking on your sales, then basically the impact on prices was very limited. I have expected here a different trend. Could you elaborate a little bit what why this was? So I do understand there is some mix effect, but nevertheless, prices have fallen down throughout the quarter and there was not materially anything seen at your side. Then going into Q4, if volume is picking up and you haven't seen anything on the price side, what does that mean then for Q4? And in that light, your guidance still looks a little bit cautious. Well, as I explained, we had volume shortfall in sales in September. We continue to produce at full load, sort of filling the logistics pipeline to Asia. And so we use that time period simply to the advantage of the customers in the future. That's what Yes, go ahead. Yes. I do understand what you said about the volume and the inventory increase you have done in various reasons to be able to act more flexible. But looking on the sales decline, if I try to figure out how much volume it was down in this particular quarter and look on the sales development, then it looks like that there wasn't a price decline. So your average price was probably, cool on cool, not much down. So what I have seen on the market was a little bit different. So maybe you haven't participated on very low prices. And then I would like to know how I have to read in the market at prices being still very low and whether you are at all affected by this in Q4. Well, as would say, one of the significant market leaders, we always think about our responsibility not to follow the lowest prices in the industry. And so we certainly did not business that we thought was ridiculously low. This just is a general statement, but without talking about individual prices, of course. And but of course, if the total price trend is going down. This also has certainly an effect on us. I mean, that's the question. And I think we had a question on Q4. I mean, as we said, we saw orders picking up in the October, and I think that's a positive momentum for the rest of the quarter. And it's still that you do not make too many compromises on the price side? Well, I mean, we are certainly one of the players in the whole field that is trying to keep the prices up as possible. But as I said before, I mean, if there is a general trend, I mean, have to follow. But we are certainly in terms of reducing prices if necessary, we are certainly not a leader. Understood. Thanks a lot. Operator, the next question is from Mr. Jean Francois Mimmedi. I have a my first question is going to be on CapEx. If I remember well, at your CapEx market today, you say EUR 400,000,000 to EUR $450,000,000 or EUR 4,000,000 to $450,000,000 CapEx for next year. If I look at your ongoing CapEx now in polysilicon, I more get to the level of €300,000,000 which means I'm missing 100,000,000 to €150,000,000 that I should put on chemicals. Therefore, looking at your expanding only downstream, that should mean that you have something penciled in for fumed silica in your guidance. Is that correct? Or is there anything abnormal about your CapEx? And the second one, going back to polysilicon, how should we think about volume development for the overall for this year? And let's say, will the sales jump in the October make up for the slow volumes in the October? Thank you. On the CapEx, yes, I think we gave you the right indication during the Capital Markets Day. I think if you, let's say, model next year with $450,000,000 it's certainly in the right range. I mean I do not expect for it to be more than that. And your conclusion is right. I mean, certainly, the investment in polysilicon is significantly down. So that means there might be some projects in Chemicals. That's right. Or in the Since you put it in your guidance, can you share with us what's behind your guidance? Well, let me put it this way. It's certainly in line or obviously in line with what we said that we want to improve our position in downstream chemicals. And there are certainly there are some projects in there that are very interesting. I as we said, for Tennessee, a fumed silica plant would be the next logical step, but there are no decisions on that and no time lines. That's why I cannot confirm your conclusion that it will be in the plan for 2017. So in other words, we do not disclose yet what the major projects of 2017 will be or potentially will be. And without let me reverse. Without big projects, would we be around the 300,000,000 mark? No, I think that's I mean, we are pursuing the strategy of investments in downstream in order to even improve our chemicals business further. And that's how you have to look at it. The next I think on the volumes, your question on the volume. I think we gave sort of an indication once that we want to be or we want to sell this year somewhat close to 70,000 tonnes. Of course, with the drop in sales in September, this might be a little bit ambitious volume target. But as we said, we want to take time to improve our logistic chain to Asia. In other words, this is not a worrisome development. I think it plays well into our hands of improving the service to our customers. Would 65,000 tonnes be a better proxy or Basically, we do not forecast that. Okay. Great. The next question for me is Peter Sveinner, DZ Bank. On the poly market situation, how long do you expect the current situation will last? So what are the main drivers? Is it more like overcapacity or the demand in China? What are the parallels to the last situation with price pressure where you gained market share? And my second question is on the Siltronic. Do you consider to sell or what's your exit strategy? Can you update us on this? Do you consider to sell several blocks? Or do you have a minimum price which you would like to have? And do you see a cyclical upside which could increase the share price near term? In polysilicon, I mean, Tobias, in his speech and also in the slide deck, you see our assumption on the market. So the solar markets are still continuing to grow. And there might be fluctuations of demand like we had in the past. But overall, as I said, we see growth in the market, and that's important. And it's very difficult to predict these, let's say, mini cycles that we see sometimes seasonally. But solar is and will remain a very, very important development and important business for energy demand or providing enough energy for the world. So that's why and polysilicon will be the basis for that for a very long time. On Siltronic, there's no change to what we said in the Capital Market Day. At some point in time, we are looking at selling off our ownership in Tiltronics, whether that will be in one portion or in several portions, we cannot say. And there's no special preference there. It really depends on the market. But on the other hand, there is no need. There's no urgency behind that. Siltronic is an excellently positioned company, excellently managed company. So we will find the right timing for that. Thank you very much. Operator, the next question is from Mr. Gupri Gudral at Macquarie. Hi, guys. I've got three questions, if I may. Firstly, how much of the operating expense in Q3 twenty fifteen, the EUR74.2 million is ramp up cost? Can you remind me of that? My second question is on China demand. If the proposed feed in tariff cuts proposed by the government is implemented, how will that impact demand, do you think, in 2017 as per your forecast in Slide 11? And finally, my third question is around the Chemicals business. You're obviously approaching very high utilization right now over 90%. What's the scope there in terms of increasing nameplate capacity perhaps through debottlenecking? Maybe on the tariffs in China. Of course, there is no final decision made yet. I think it's expected by November if we have the right information. And of course, has surprised us in the past and especially this year. And I think there are still cost cuts possible as well in the whole value chain. So we are not too worried about the growth in China, as you can see at our estimates on Page 11. It should be, in 2017, again, in the range of 16 to 23 gigawatts. And is that forecast assuming a certain scenario in terms of that proposed change to feed in tariffs? Well, we certainly have some underlying estimates on the feeding tariffs. But I think they are within the range that are in discussion right now. Okay. With respect to the pre operational costs in 2015, we said that the full year impact of that was some EUR 90,000,000, and we didn't give any specifics on the quarter. So but as we approach the ramp, we had more costs pre ops in the second half of the year. So if you sort of try to model that along that slope, I think you would get a fair number. Okay. And actually, the third part, we really did not understand acoustically. If you could repeat that. Sure. I was just wondering what the scope is in terms of increasing the nameplate capacity of your chemicals business. You're obviously reaching very high utilization. Can you provide us some color as to the possibilities of increasing the overall capacity of the silicones and polymers business? I mean, it's a challenge to look into the future and give you a precise number for the next years. We certainly have opportunity to debottleneck. We have some material in the Capital Market Day presentation for two key products, the siloxane for silicones and the dispersions for polymers, where you can see that we typically we have yes, the opportunity to go far beyond the nameplate capacity. I would suggest to look at that page. That gives you an indication. And for the account for the raw material of silicon siloxane, of course, we have enough capacity. We have opportunities to debottleneck at very low cost. We certainly will not put a lot of money in the upstream capacities, not at all. And in silicones, we also have the opportunity to turn material that is used more on the commodity side or standard side onto a product in the specialty side. So we have these two variabilities that we can use to grow definitely with the demand of our customers. So there is no restriction on capacity there. Thank you. Operator, the next question is from Ms. Tanja Marklov at Commerzbank. Good afternoon. Would it be possible to have an indication on your U. S. Dollar sensitivity on on next next year year in in terms terms of of revenue revenue and costs taking into account the new plant in Tennessee? Yes. I would go for the 2016 numbers. We don't have a plan for next year yet, but I wouldn't assume big changes. So if you take a €01 change that gives you roughly a €10,000,000 sales change in Chemicals and a €2,000,000 point change in EBITDA because we have some quite substantial natural hedging in Chemicals. In Siltronic, that €1 change in the exchange rate would mean some €5,000,000 in sales and some €3,000,000 in EBITDA for Siltronic. Typically, we do some 50% hedging. So the numbers that I said for EBITDA impact is typically 50% when assuming a hedge rate of 50%. Got you. Thank you very much. Operator, the next question is from Mr. Andrew Heap at Berenberg. Hi. Could I just ask about inventory levels? So we've had a step up of about $80,000,000 if you exclude Siltronic. And I think we can fairly safely assume that's all down pretty much all down to polysilicon. What do you see the current level with the extra logistics as a sustainable level? Or would you like to reduce that back down and reduce the inventories you built up either in Q4 or in 2017? And then secondly, could I just ask what pricing pressure you're feeling in polymers from like recent capacity additions from competitors in Asia? In terms of polysilicon volumes that we have increased in inventory, we do not see a reduction of that. We really want to keep that in order to improve our service capability for the customers. Okay. The second question on polymers was could you repeat it again? Just how much pricing pressure you're feeling from the likes of Celanese in Singapore? Okay. So I mean, we see price decreases, I mean, at a similar magnitude over the quarters against prior year. So there's no fundamental change. And if you're, yes, asking about the regional split, yes, there's more pricing pressure in Asia. That's right. But it's trend that this is increasing against last year. Okay. Operator, the next question is from Mr. Peter Mackey at BNP Paribas. Good afternoon all. Yes, I have just one simple question or very naive question remaining. If I look at the polysilicon division, if I just do a very simple sales minus EBITDA and adjust for the ramp up costs you guided to in the first couple of quarters, The those sort of cash costs have actually been declining quarter on quarter for the last three quarters. And that's despite the ramp up of Tennessee. I assume that an element of that is you have capitalized some costs into inventory in the third quarter. But I just wonder if you could sort of talk a little bit about the fixed cost base in light of Tennessee ramping up and how we should think about the fourth quarter, please? That's a very intelligent question, I would say. Not sure about intelligence. You're right that we had I mean, we had the ramp cost in the first half, some €30,000,000 and €18,000,000 in Q1 and Q2, which are very much cash cost. We are talking about EBITDA cost. And so that is due to the ramp. So you have to I mean, ramping up such a plant, you need to prepare for the processes for all the loops. And that is additional cost, which is, yes, not recurring. But on the other hand, if you are starting a plant like Tennessee, you get very close to the level of the fixed cost already early on as soon as you start because it's fixed cost. So it's we do not detail that, but it's a function of the two elements. Right. Okay. So we should but in the third quarter particularly, you'll have capitalized a chunk of the fixed cost presumably? Yes. That's typically accounting if you have an inventory increase that we talked about, you that capitalization of the fixed cost. That's right, yes. Thank you. Operator, next question is from Mr. Carsten Erken at Bantoux Lampe. Yes. Hello, thanks. I'm just curious, you mentioned that polysilicon demand improved substantially or improved in October. And I'd love to quantify this. I'm sure you wouldn't want good numbers. But are you still building inventory as of today? Are you still is the production still outstripping demand? Well, as I said, we purposely built inventory. I mean In September, I guess, end October. Yes, in October as well, but far less than in September. But I mean, if we wanted, we could sell inventory, but at a price level that we are not interested in. And just now going into November, so sort of as of today, are you still building inventory? Or is it now sort of in balance, production and demand? We do not forecast that. But as Tobias said, the momentum that we are seeing in an increase in orders looks promising. And do you see competitors re ramping capacity already again? Or are they still shutting down? I mean they have some of them had regular maintenance shutdowns just as we have sometimes. They did it really at the right time. Just as we have maintenance at the right time in the third quarter. And but I assume that they will ramp up capacity very soon. I mean, I don't know the details of that. And one last question. On Tennessee production volume, should we model full volumes for Q4 already? Or should we wait until Q1 for that? I would say it's very close to full capacity. With such a new plant, I think the ramp up was beautiful for such a big addition on the greenfield. I mean you have to consider that. So the ramp up basically was very similar to what we had in interest, and interest was brownfield. So there was already an existing chemical plant with experienced operators, etcetera, etcetera. And Tennessee basically did almost the same. So after nine months of ramp up being very close to full capacity, I think it's something our people can be proud of. Yes, definitely. So all we need is a market to take the volume. That's great. Thank you. Operator, the next question is from Mr. Thomas Swabhler, Societe Generale. Yes, good afternoon, gentlemen. I have just I have only one question left, and it is on chemicals. And in especially on the price pressure you mentioned in in both in in silicones and polymers. I mean, I'm still a little bit intrigued. At the same time said the utilization rates in Q3 reached above 90%, which quite good. So could you take us through the areas where you see the price pressure? And what is driving it? And what should we think about the next couple of quarters? I take the question, Thomas. The price pressure definitely comes from also our raw material input prices. I mean, have some areas where we also said where we have formula pricing that is one to one pass through. But overall, I mean, given the situation on our input side, our net pricing is still positive. And net pricing means the pricing of our products against the pricing of raw materials. And it's depending on product by product and also region. So there's no clear picture, and it's been very similar over the quarter. So it's year over year comparison, Q1, Q2, Q3 look really very similar and with respect to price development. May I ask you a little bit differently? Are your customers asking you actively for a pass through on the raw materials? Or is it would that be going too far? So customers ask for pass through of raw material prices when raw material prices are going down, and they forget it when prices So are going I mean, with many customers, we have annual, semiannual contracts. And every time we go into the discussion with the customers, of course, there is a discussion about pricing. That's standard. So it's not unusual that customers are asking for lower prices. We just have to convince them that they get so much additional value from our material that we can resist this wish. Perfect. I understood. Thank you very much. Thank you. Sure. Thank you. Operator, do we have more questions? At the moment, there seem to be no further questions. Operator, we have one question from Mr. Markus Mayer at Baader. Actually, two questions. One is on the slight price decline in Wacker Biosolutions. Is this coming from the GAM products or from your fine chemical metal productions? And secondly, can you give us an update on the process of your large maintenance work in Bockhausen? Is this running well? You probably mean the shutdown of the canal to the That actually has been restarted today. Energy is produced hydroelectric energy is produced again today. And the whole project went extremely well. We it was finished almost two weeks earlier than originally planned and about 10% under budget. Very good. And with respect to pricing in BioSolutions, that is mainly indeed gone, as you assumed, and that's a perfect example for raw material pass through from formula pricing. Because VAM pricing, our input material is lower than last year. Operator, Okay. We Thanks. Have a question from Mr. Martin Jungfels at Kepler Cheuvreux. Yes. Hi. Thanks for taking my question. Just a few questions on polysilicon to follow-up. Do you expect volumes in the fourth quarter to recover to levels seen in the first or second quarter this year? So it will be less or more volume. And in terms of demand, is it just China that was weak in September? Or is it also other regions? And then lastly, on the cost performance, do you expect further production cost improvement for polysilicon, especially in Germany? Well, we never made forecasts on polysilicon volumes specifically for a quarter. As I mentioned before, it's very difficult to do that at this point because we select whether we put material in inventory or whether we are going to sell it. But overall, I would say momentum is good. But it's very difficult except for long term contracts. But on short term contracts, it's hard to say what will happen in December. But at this point in time, we have no reason to assume that we see something like in September. Okay. With respect to policy cost reduction, I mean, we communicated that this is a strong focus of all our businesses. And this is there's a clear cost roadmap for all plants, all polysilicon plants, and that definitely includes the two German plants and that also includes now Tennessee. We do not give the details on that, but there's something baked into our future. With respect to the end markets, China that has slowed, I mean, was so much discussion about that very strong first half of the year and then the slowdown in the third quarter, yet it was very much China. Okay. Thanks. Thank you all for joining us today and for your interest in Wacker Chemie. We're looking forward to further discussions with you at support of prices. We expect to publish our full year preliminary results at the January or early February next year, So stay tuned. And we'll be back again with a conference call on March 14 with the full year results in 2017. Goodbye.